Wang Chun-Hua, Yu Chao, Zhuang Lei, Xu Feng, Zhao Li-Hua, Wang Xiao-Hua, Ning Li-Yan, Zhang Xiu-Lin, Zhang Dong-Mei, Wang Xue-Qin, Su Jian-Bin
Department of Endocrinology, Affiliated Hospital 2 of Nantong University, First People's Hospital of Nantong City, No. 6 Haierxiang North Road, Nantong, 226001, China.
Department of Clinical Laboratory, Affiliated Hospital 2 of Nantong University, First People's Hospital of Nantong City, No. 6 Haierxiang North Road, Nantong, 226001, China.
Diabetol Metab Syndr. 2022 Sep 27;14(1):142. doi: 10.1186/s13098-022-00909-7.
Increased serum carcinoembryonic antigen (CEA) levels are reported to be associated with various metabolic and inflammatory diseases. This study assessed whether high-normal serum CEA is related to diabetic peripheral neuropathy (DPN) in patients with type 2 diabetes (T2D).
All subjects received DPN assessment based on neuropathic symptoms, neuropathic signs, and nerve conduction studies to calculate composite Z scores of nerve latency, amplitude and conduction velocity (NCV). DPN was confirmed by both at least a presentation of neuropathic symptoms/signs and an abnormal nerve conduction index. Serum CEA levels and other clinical indices were also synchronously detected. Multivariable linear regression analyses were used to determine the independent effects of serum CEA levels on nerve conduction indices, multivariable logistic regression analyses were used to determine the independent impact of CEA levels on the risk of DPN, and receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic capability of CEA levels to discriminate DPN.
We ultimately recruited 402 eligible subjects with normal ranges of serum CEA for this study, and 25.4% (n = 102) were determined to have DPN. After adjusting for other clinical covariates, serum CEA levels were independently associated with the composite Z score for latency (β = 0.132, t = 2.330, p = 0.021), amplitude (β = - 0.164, t = - 2.838, p = 0.005) and NCV (β = - 0.210, t = - 3.662, p < 0.001). Moreover, the prevalence of DPN in the first, second, third and fourth quartiles of CEA level was 12.9%, 19.0%, 29.4% and 40.4%, respectively (p for trend < 0.001); the corresponding adjusted odds ratios and 95% CIs for DPN in CEA quartiles were 1, 1.47 (0.45-4.82), 1.72 (0.54-5.53) and 4.58 (1.39-15.06), respectively. Furthermore, the optimal cut-off value of high-normal serum CEA to discriminate DPN was ≥ 2.66 ng/mL, with a Youden index of 0.28, sensitivity of 66.67% and specificity of 61.00%.
Increased serum CEA levels within the normal range are closely linked to dysfunction of peripheral nerve conduction and the risk of DPN, and high-normal serum CEA levels are a potential risk factor for DPN in T2D.
据报道,血清癌胚抗原(CEA)水平升高与多种代谢和炎症性疾病有关。本研究评估了血清CEA处于高正常水平是否与2型糖尿病(T2D)患者的糖尿病周围神经病变(DPN)相关。
所有受试者均根据神经病变症状、体征以及神经传导研究接受DPN评估,以计算神经潜伏期、波幅和传导速度(NCV)的综合Z评分。通过至少出现神经病变症状/体征以及异常的神经传导指数来确诊DPN。同时同步检测血清CEA水平和其他临床指标。采用多变量线性回归分析来确定血清CEA水平对神经传导指数的独立影响,采用多变量逻辑回归分析来确定CEA水平对DPN风险的独立影响,并采用受试者工作特征(ROC)曲线分析来评估CEA水平鉴别DPN的诊断能力。
本研究最终招募了402名血清CEA范围正常的合格受试者,其中25.4%(n = 102)被确定患有DPN。在调整其他临床协变量后,血清CEA水平与潜伏期综合Z评分(β = 0.132,t = 2.330,p = 0.021)、波幅(β = -0.164,t = -2.838,p = 0.005)和NCV(β = -0.210,t = -3.662,p < 0.001)独立相关。此外,CEA水平第一、二、三、四分位数中DPN的患病率分别为12.9%、19.0%、29.4%和40.4%(趋势p < 0.001);CEA四分位数中DPN的相应调整比值比和95%置信区间分别为1、1.47(0.45 - 4.82)、1.72(0.54 - 5.53)和4.58(1.39 - 15.06)。此外,鉴别DPN的血清CEA高正常水平的最佳截断值为≥2.66 ng/mL,约登指数为0.28,灵敏度为66.67%,特异性为61.00%。
正常范围内血清CEA水平升高与周围神经传导功能障碍和DPN风险密切相关,血清CEA高正常水平是T2D患者发生DPN的潜在危险因素。